Gilteritinib vs salvage chemotherapy in FLT3-mutated acute myeloid leukemia: number needed to treat for clinical outcomes per a secondary analysis of the ADMIRAL trial.
作者信息
Zeidan Amer M, Qi Cynthia Z, Yang Hongbo, Garnham Andy, Shah Manasee V, Pandya Bhavik J
机构信息
Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.
Analysis Group, Inc., Boston, MA, USA.
出版信息
Leuk Lymphoma. 2022 Mar;63(3):762-764. doi: 10.1080/10428194.2021.2001467. Epub 2021 Nov 8.
Abstract
摘要
Zotero 插件